Vinod Chandran Selected Research

tridecanedioic acid

1/2021

Serum metabolic fingerprinting of psoriasis and psoriatic arthritis patients using solid-phase microextraction-liquid chromatography-high-resolution mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vinod Chandran Research Topics

Disease

63	Psoriatic Arthritis 01/2022 - 07/2007
49	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 09/2009
20	Arthritis (Polyarthritis) 06/2021 - 04/2010
8	Rheumatoid Arthritis 01/2022 - 03/2012
7	Inflammation (Inflammations) 08/2020 - 02/2013
7	Osteoarthritis 01/2020 - 02/2013
6	Fatigue 01/2020 - 07/2007
5	Ankylosing Spondylitis 01/2022 - 12/2010
5	Necrosis 12/2020 - 12/2013
5	Back Pain (Backache) 12/2020 - 04/2010
5	Pain (Aches) 12/2020 - 12/2017
3	Neoplasms (Cancer) 01/2021 - 01/2020
3	Chronic Disease (Chronic Diseases) 01/2020 - 07/2007
3	Infections 02/2016 - 08/2011
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2020
2	Liver Diseases (Liver Disease) 01/2020 - 12/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 12/2013
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2017 - 02/2013
2	Sacroiliitis 08/2013 - 04/2010
2	Disease Progression 02/2013 - 12/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2012 - 10/2006
1	COVID-19 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Heart Failure 01/2022
1	Carotid Artery Diseases 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Diabetes Mellitus 01/2021
1	Axial Spondyloarthritis 01/2021
1	Peroxisomal Disorders (Peroxisomal Disorder) 01/2021
1	Uveitis 01/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Skin Diseases (Skin Disease) 01/2019
1	Joint Diseases (Joint Disease) 01/2019
1	Synovitis 01/2019
1	Nail Diseases (Nail Disease) 04/2018
1	Pathologic Processes 01/2018

Drug/Important Bio-Agent (IBA)

28	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2010
9	Biological ProductsIBA 01/2021 - 12/2010
8	Methotrexate (Mexate)FDA LinkGeneric 04/2018 - 03/2008
7	C-Reactive ProteinIBA 01/2022 - 07/2010
7	Antirheumatic Agents (DMARD)IBA 01/2022 - 12/2011
6	HLA-C Antigens (HLA-C)IBA 01/2019 - 01/2012
6	Proteins (Proteins, Gene)FDA Link 11/2017 - 10/2006
6	HLA-B Antigens (HLA-B)IBA 01/2017 - 04/2010
4	ixekizumabIBA 01/2022 - 01/2017
4	ProteomeIBA 01/2019 - 01/2015
3	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2018
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 10/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020 - 08/2013
3	Interleukin-17 (Interleukin 17)IBA 12/2020 - 12/2016
3	ametantrone (HAQ)IBA 12/2020 - 03/2012
3	Serine Proteases (Serine Protease)IBA 08/2020 - 02/2013
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2020 - 01/2019
3	Cartilage Oligomeric Matrix ProteinIBA 01/2019 - 02/2012
3	Genetic Markers (Genetic Marker)IBA 11/2018 - 08/2012
3	Pharmaceutical PreparationsIBA 07/2014 - 07/2010
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 08/2020
2	AdiponectinIBA 01/2019 - 12/2013
2	AntigensIBA 11/2018 - 01/2012
2	EnzymesIBA 01/2018 - 07/2010
2	Interleukin-13IBA 06/2015 - 09/2011
2	AdipokinesIBA 02/2014 - 12/2013
2	Tumor Necrosis Factor InhibitorsIBA 06/2013 - 03/2012
2	Interleukin-6 (Interleukin 6)IBA 07/2012 - 02/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2011 - 08/2011
1	mRNA VaccinesIBA 01/2022
1	tofacitinibIBA 01/2022
1	AutoantibodiesIBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	cyclic citrullinated peptideIBA 12/2021
1	Rheumatoid FactorIBA 12/2021
1	Amino Acids FDA Link 06/2021
1	LipidsIBA 06/2021
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	pembrolizumabIBA 01/2021
1	tridecanedioic acidIBA 01/2021
1	4-sulfophenylmethallyl ether (SPME)IBA 01/2021
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 12/2020
1	Biocompatible Materials (Biomaterials)IBA 06/2020
1	Alkaline PhosphataseIBA 01/2020
1	Transaminases (Aminotransferases)IBA 01/2020
1	PAR-2 ReceptorIBA 01/2020
1	Nerve Growth Factor (NGF)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Complement Factor D (Factor D)IBA 01/2019
1	InterleukinsIBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2019
1	ResistinIBA 01/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2019
1	AutoantigensIBA 01/2019
1	Hyaluronic Acid (Hyaluronan)IBA 01/2019
1	LeptinIBA 01/2019
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 11/2018
1	RNA (Ribonucleic Acid)IBA 05/2018

Therapy/Procedure

22	Therapeutics 01/2022 - 07/2007
3	Ambulatory Care (Outpatient Care) 01/2021 - 04/2010
1	Biological Therapy 12/2020
1	Injections 08/2020